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OBJECTIVES This study correlated the electron beam computed tomographic (EBCT) calcium scores with
the results of coronary angiography in symptomatic patients in order to assess its value to
predict or exclude significant coronary artery disease (CAD).
BACKGROUND Electron beam computed tomography is a sensitive method to detect coronary calcium.
However, it is unclear whether it may play a role as a filter before invasive procedures in
symptomatic patients.
METHODS A total of 1,764 patients (1,225 men and 539 women) with suspected CAD from a single
center were included in our study. All patients underwent calcium screening with EBCT
(C150XP Imatron) and conventional coronary angiography.
RESULTS Fifty-six percent of men and 47% of women revealed significant coronary stenoses ($50%).
Total exclusion of coronary calcium (14% of the study group) was associated with an
extremely low probability of stenosis (,1%). With calcium scores $20th, $100th or $75th
percentile of age groups, the sensitivity to detect stenoses decreased to 97%, 93% and 81%,
respectively, in men and to 98%, 82% and 76%, respectively, in women. At the same time, the
specificity increased up to 77% in men and women. There was a significant difference in
coronary calcium between men and women in all age groups; however, receiver-operating
characteristic curves indicated that the test can be performed with equal accuracy in all of
these subgroups.
CONCLUSIONS Calcium screening with EBCT is a highly sensitive and moderately specific test to predict
stenotic disease. Exclusion of coronary calcium defines a substantial subgroup of patients,
albeit symptomatic, with a very low probability of significant stenoses. (J Am Coll Cardiol
2001;37:451–7) © 2001 by the American College of Cardiology
Electron beam computed tomography (EBCT) can accu-
rately detect coronary calcium, which indicates the presence
of coronary atherosclerosis (1–5). Coronary calcium, as seen
in the early stage of coronary artery disease (CAD), is
closely correlated with fatty “soft” plaques, which may
rupture and cause myocardial infarction (6,7). However, the
correlation between arterial mineralization and the proba-
bility of plaque rupture is unknown. In symptomatic pa-
tients, EBCT calcium screening has been used to estimate
the severity of stenosis. No close correlation, however, could
be found between the amount of calcium and arterial lumen
narrowing (8–13). In this study, we included 1,764 symp-
tomatic patients with suspected CAD and compared the
findings of coronary calcium screening, as assessed with
EBCT and conventional coronary arteriography.
METHODS
Calcium screening. Electron beam computed tomography
(C150XP Imatron) was used to determine coronary cal-
cium. The scanner operated in the high resolution volume
mode (630 mA, 130 kV, scanning time 100 ms, 40 slices
a` 3 mm, 512 3 512 matrix, 26-cm field of view, sharp
kernel). Prospective electrocardiographic triggering in
mid-diastole (80% of the RR interval) was applied during a
single inspiratory breath-hold. The calcium score was
calculated with Imatron’s implemented software, according
to the method of Agatston et al. (14). A calcified plaque
was defined as a lesion of at least two adjacent pixels
(.0.51 mm2) with a signal density .130 Houndsfield units.
Coronary angiography. The Judkin’s technique was used
with at least four views of the left system and two views of
the right system. Analysis of the coronary angiograms was
done by an independent, experienced observer who was
unaware of the calcium score. The decision to perform
angiography was not influenced by the calcium score.
Angiography was performed within four days after the
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EBCT scan in 78%, within 10 days in 98% and within 30
days in the remaining 2% of the patients. Significant
stenosis was defined as $50% lumen narrowing of any
epicardial coronary artery.
Patient group. A total of 1,764 consecutive patients who
were referred for coronary angiography because of suspected
CAD were included in this single-center study. All patients
fulfilled the following inclusion criteria: typical or atypical
chest pain and/or signs of myocardial ischemia on nonin-
vasive tests (bicycle stress test, in most cases) and a clinical
indication for cardiac catheterization. Patients were ex-
cluded if they had CAD documented by before cardiac
catheterization or were specifically referred for coronary
interventions. Thus, at the time of angiography, the pa-
tient’s diagnosis was unclear. Consecutive patients fulfilling
these criteria from July 1997 to November 1999 were
included in this study. They form a subset from a total of
5,300 patients who underwent cardiac catheterization with
coronary angiography at our institution during this period.
Statistical analysis. Because of the non-normality, statis-
tical analysis was performed on the base 10 log of the
transformed calcium score. The Wilcoxon signed rank test
for unpaired data was used to compare the calcium score in
different age groups and between men and women with and
without significant CAD. Receiver-operating characteristic
(ROC) curve analysis was performed as follows: the true
positive rate (sensitivity) was plotted as a function of a false
positive rate (1 2 specificity) for predicting $50% angio-
graphic stenoses for all possible threshold calcium scores.
The ROC curve areas are given for all age groups. A curve
area of 1.0 represents a perfect test, with 100% sensitivity
and 100% specificity. Curve areas $0.7 indicate a reason-
ably good clinical test. In addition, coronary calcium scores
in each age group were ranked in ascending order to
calculate percentiles. Patients with calcium scores in the
highest quartile ($75%) were analyzed separately.
RESULTS
The study comprised 1,225 men and 539 women between
20 and 80 years old (56 6 14 years in men and 60 6 16
years in women, p 5 NS). “Chest pain” compatible with
angina was reported by 65% of the patients. A stress test was
available in 920 patients, which was abnormal (including
borderline results) in 52%. Forty-one percent of the indi-
viduals were smokers. Coronary angiography revealed sig-
nificant CAD ($50% stenosis) in 56% of men and 47% of
women (high grade stenosis $75% in 37% of men and 30%
of women). There were 302 men (25%) and 220 women
(41%) with normal coronary arteriograms. Diagnostic arte-
riography resulted in interventions in 463 patients (75% of
patients with stenosis $75%) (percutaneous transluminal
coronary angioplasty with or without stent implantation,
coronary artery bypass graft surgery in 12 patients).
The calcium scores for men and women (Tables 1 and 2)
indicate that: 1) the mean score in men was significantly
higher than that in women (p , 0.0001) at each age class;
2) for both genders, there was a significant increase in
calcification with age; 3) the variability of scores within each
age class was high (as indicated by the high standard
deviation); this was caused by a minority of patients with
excessive calcification; and 4) the difference between pa-
tients with and without significant CAD was highly signif-
icant for the total group of patients and within each age
group.
Table 1. Calcium Scores in Symptomatic Men and Women
Men Women
n Score n Score
Without significant CAD
Age (years)
,40 78 4 6 8 86 5 6 11
40–50 93 36 6 88 25 4 6 15
50–60 164 115 6 345 45 45 6 126
60–70 149 191 6 328 80 53 6 89
.70 56 275 6 308 48 151 6 211
S 540 123 6 289* 284 49 6 121*
With significant CAD ($50% stenosis)
Age (years)
,40 91 122 6 184 39 108 6 162
40–50 96 358 6 590 56 116 6 265
50–60 156 620 6 910 46 222 6 374
60–70 202 862 6 1,066 67 396 6 522
.70 140 1,196 6 1,407 47 942 6 1,146
S 685 706 6 1,047* 255 360 6 665*
*p , 0.001, also true for all age groups. Score values are presented as the mean 6 SD.
CAD 5 coronary artery disease.
Abbreviations and Acronyms
CAD 5 coronary artery disease
EBCT 5 electron beam computed tomography
ROC 5 receiver-operating characteristic
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Exclusion of coronary calcium. No calcium was found in
128 (23.7%) of 540 men and in 116 (40.8%) of 284 women
without significant CAD, as compared with 5 (0.7%) of 685
men and 0 of 255 women with coronary stenoses $50%
(Table 3). Thus, exclusion of coronary calcification was
associated with an extremely low probability of significant
stenosis in men and women. In contrast, there was a
considerable number of patients without stenoses who,
although symptomatic, did not reveal any calcification: 55%
of symptomatic men and women ,40 years of age had no
calcification. In this group, the risk of stenosis was 0%. The
prevalence of “no calcium” decreased with age, but even in
the age group 60 to 70 years, 12% of men and 32% of
women were free of calcium and had no apparent risk of
significant coronary lesions (Table 3). However, even the
complete absence of coronary calcium did not totally ex-
clude high grade coronary stenosis, although this was a very
rare finding (n 5 5, only 2 of whom required intervention).
Accuracy of the test at different score levels. The positive
finding of coronary calcium (score .0), as expected, had the
best sensitivity (99% in men and 100% in women) and the
best negative predictive power (97% in men and 100% in
women) to detect stenosis $50% and stenosis $75% in men
and women (Table 4, upper left panel). The specificity (23%
in men and 40% in women) was poor, and the positive
predictive value of this variable was moderate.
A score $20 was sensitive, but only moderately specific,
to detect stenosis (Table 4, upper right panel). In contrast,
a score ,20 was a powerful variable to exclude stenotic
disease: only 16 (5.9%) of 267 men (22% of study group)
and 1 (0.5%) of 183 women (34% of study group) with a
score #20 had significant CAD.
Several more patients had a score $100 (Table 4, lower
left panel), indicating severe plaque burden, and sensitivity
was reduced, especially in women.
Score values in the $75th percentile of the age group
were even less sensitive, but resulted in the best specificity in
women.
The ROC curve areas for all age groups and both genders
with significant CAD ($50% stenosis) are given in Table 5.
The values are all .0.75, indicating that the test can be
performed with similar accuracy in all age groups, irrespec-
tive of gender.
Clinical useful score cutpoints for management deci-
sions. In Figure 1 (for men) and Figure 2 (for women), the
scores are divided into three levels for each age group: the
lower range defines 95% of patients without significant
stenoses. Thus, up to the lower score threshold, significant
CAD in a symptomatic person is very unlikely. The upper
range includes 90% of patients with significant stenoses.
Calcium levels beyond the upper score threshold are asso-
ciated with obstructive disease in the majority of patients. In
the white zone, diagnosis is uncertain. The white zone
consisted of 98 men (8%) and 40 women (7.4%). A narrow
white area indicates an excellent test variable, with only a
few patients in the indefinite zone (approaching a “yes” or
Table 2. Calcium Score Nomogram for 1,764 Symptomatic Subjects
Age (yrs)
<40 40–50 50–60 60–70 >70
Men (n 5 1,225) n 5 169 n 5 189 n 5 320 n 5 351 n 5 196
25th percentile 0 34 61 156 176
50th percentile 23 78 193 342 407
75th percentile 45 229 593 670 1,068
90th percentile 156 576 954 1,562 2,694
Women (n 5 539) n 5 125 n 5 81 n 5 91 n 5 147 n 5 95
25th percentile 0 0 18 46 68
50th percentile 0 27 42 127 362
75th percentile 552 67 168 208 697
90th percentile 138 148 467 523 1,498
Table 3. Exclusion of Coronary Calcium (Score 5 0)
Men Women
Significant CAD (Stenosis >50%)
No Yes No Yes
Age (years)
,40 43/78 (55%) 0/91 (0%) 47/86 (55%) 0/39
40–50 30/93 (32%) 1/96 (1%) 21/25 (84%) 0/56
50–60 35/164 (21%) 2/156 (1%) 18/45 (40%) 0/46
60–70 18/149 (12%) 1/202 (0%) 26/80 (32%) 0/67
.70 2/56 (4%) 1/140 (1%) 4/48 (8%) 0/47
Total 128/540 (24%) 5/685 (0.7%) 116/284 (41%) 0/255
Data are presented as the number of patients with score 5 0/total number of patients in that age group, with percentages in
parentheses.
CAD 5 coronary artery disease.
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“no” decision). According to this, EBCT calcium screening
was especially helpful in men ,50 years old and in women
,60 years old.
DISCUSSION
This study describes the value of EBCT calcium screening
in symptomatic patients who were referred to our center
with suspected CAD to be proven or excluded by coronary
angiography. The strength of this study is that all the
patients were evaluated in a single center with the same
technology; EBCT scans and angiography were performed
within a few days of each other and were read by indepen-
dent observers in a blinded manner. It is the largest study
published. The main results are as follows: exclusion of
coronary calcium was associated with a very low risk of
significant CAD (,1%). Eleven percent of men and 22% of
women, although symptomatic with a high pretest proba-
bility of CAD and an indication for coronary angiography,
did not show any coronary calcium; thus, this variable
appears to be helpful as a filter before invasive procedures.
Higher calcium score values ($20th, $100th and $75th
percentile of a given age group) are associated with de-
creased sensitivity to detect significant CAD, but increased
specificity of the method. The quantification of calcium
allowed exclusion of atherosclerotic disease in a subset of
patients, and strongly predicted obstructive disease in oth-
ers. There was a significant difference in coronary calcium
between men and women of all age groups; however, the
reliability of calcium testing in predicting significant steno-
sis was equally effective in men and women. Finally, the
diagnostic benefit of calcium screening is maintained for all
age groups.
Mechanism of calcification. Coronary calcium predomi-
nantly consists of calcium phosphate (hydroxyapatite),
which is not only absorbed or deposited passively, but also
forms in situ by an organized, regulated process (15–17).
Coronary calcium is strongly associated with the total
plaque burden, as has been evaluated in histopathologic
studies (1,2). It is not a direct marker of the vulnerable
plaque at risk of rupture; however, the greater the calcium
score, the greater the potential for increased numbers of
potentially lipid-rich plaques, which are widely thought to
be the culprit lesions of acute coronary syndromes. Lesser
obstructive plaques are associated with a higher incidence of
coronary occlusion, as compared with severely obstructed
plaques. This occurs not because of the higher risk of such
Table 4. Sensitivity and Specificity of Coronary Calcifications at Different Score Levels
Score >0 (“Any Calcium Detected”) Score >20
Stenosis Stenosis
>50% >75% >50% >75%
M F M F M F M F
Sensitivity 99% 100% 99% 99% 97% 98% 98% 98%
Specificity 23% 40% 39% 49% 62% 69% 51% 64%
PPV 62% 66% 57% 53% 62% 70% 48% 59%
NPV 97% 100% 99% 99% 95% 91% 96% 94%
Score >100 Score >75% Percentile of Age Group
Stenosis Stenosis
>50% >75% >50% >75%
M F M F M F M F
Sensitivity 93% 82% 95% 89% 81% 76% 78% 75%
Specificity 75% 76% 79% 79% 72% 77% 83% 85%
PPV 76% 78% 71% 73% 65% 71% 67% 72%
NPV 79% 72% 85% 81% 70% 69% 77% 75%
NPV 5 negative predictive value; PPV 5 positive predictive value.
Table 5. Receiver-Operating Characteristic Curve Areas for Patients in Different Age Group,






Women Men Women Men
,40 0.83 0.86 0.83 0.91
40–50 0.76 0.79 0.87 0.84
50–60 0.87 0.79 0.86 0.81
60–70 0.78 0.89 0.79 0.84
.70 0.79 0.81 0.83 0.82
CAD 5 coronary artery disease.
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plaques in and of themselves, but because of their much
greater number (6). Angiography is not the gold standard to
validate the significance of coronary calcification. Major
discrepancies have been found between the angiographic
severity of lesions and postmortem examinations (18–23),
with angiography underestimating the extent of atheroscle-
rosis (4,24). Morphology and functional consequence of
stenoses may differ substantially (25,26).
Study group selected. The results should be seen in the
light of the selection criteria chosen. We included patients
who were referred for invasive coronary angiography be-
cause of symptoms suspicious of CAD. Our patients had
typical or atypical chest pain and/or signs of ischemia during
bicycle stress tests, which were borderline or inconclusive in
many patients (e.g., those with ST segment abnormalities
that failed to reach significance or those whose interpreta-
tion was difficult because of bundle branch block or female
gender). Thus, the pretest probability of CAD in this
patient group was high (;50% of the patients had signifi-
cant stenoses). In contrast, the use of symptoms and
conventional noninvasive methods turned out to be quite
poor in predicting obstructive disease at angiography (only
50% had stenoses). Seventy-five percent of the patients with
$75% stenoses went on to therapeutic interventions, but
this group amounted to only 26% of the total group studied.
This is in good agreement with the experience of other
centers using interventional procedures in about one of three
diagnostic tests, ranging from 1:1 to 1:4 at different sites.
For all of the patients in our center, 65% of the diagnostic
procedures led to interventions.
Diagnostic yield. Our results show that EBCT calcium
screening can identify a subset of patients with a very low
risk of significant CAD in whom invasive diagnostic pro-
cedures may be omitted. Absence of coronary calcium (11%
of men and 22% of women) was associated with a very low
probability of obstructive disease (0.7% in men and 0% in
Figure 1. Diagnostic yield of calcium screening in symptomatic men. The lower scores define the calcium score thresholds for the 95% of patients without
significant stenoses. The higher scores give the calcium score thresholds for the 90% of patients with significant stenoses. Within the central area, the
diagnosis is uncertain. The numbers in parentheses give the number of patients within the area. For example, a man at the age of 50 years is probably free
of coronary stenosis if his score is ,56. At score values .217, he bears a high risk of stenosis.
Figure 2. Diagnostic yield of calcium screening in symptomatic women. For explanation, see Figure 1.
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women). Patients with high grade stenoses, but no calcifi-
cation, are extremely rare.
There is no agreement on what score cutpoint should be
used in the clinical setting. Some studies solely used
exclusion of any calcium (8–12,27). Other studies used a
fixed score of 100 (28) or an optimized cutoff value,
irrespective of age and gender (8). Our study group is large
enough to calculate cutpoints for each decade of age and
separately for men and women.
Calcium screening with EBCT was especially helpful in
patients up to the age of 50 years. In this age group, the
prevalence of “no calcium” is higher (21% in men and 33%
in women), and the “white zone” (Fig. 1 and 2) is small.
These findings are consistent with some previous reports
(9,12), but not with others (11,29). The differences are
probably due to the selection criteria and the small numbers
in these studies.
Analysis of the ROC area (Table 5) indicates that the
ability to identify patients with coronary obstructive disease
is equally good in all age groups, irrespective of gender, and
is better than conventional bicycle stress testing (ROC area
;0.75) (30). The diagnostic accuracy of EBCT calcium
screening has been found to be superior to conventional risk
factor analysis (31) and equal to or better than conventional
stress tests. The exercise stress test is characterized by a wide
variability of sensitivity, specificity and diagnostic accuracy
(mean sensitivity 81% [range 40% to 100%], specificity 66%
[range 17% to 100%]) (32). The test results are influenced
by gender, drugs, bundle branch block and an inability to
exercise sufficiently. Moreover, the test is not free of
complications (32–34). In contrast, EBCT calcium screen-
ing can be performed quickly, cost-effectively and with no
risk to the patient. As an alternative, stress radionuclide
scintigraphy has been proposed, but this test is limited by
variable sensitivity and specificity, high radiation exposure
and a time-consuming protocol (35–39).
Electron beam computed tomography gives the chance to
combine, in one session, calcium scanning and CT-
angiography to evaluate the morphology of coronary arteries
after injection of a contrast agent. However, no data on such
a combined approach are available. Schmermund et al. (40)
used EBCT-angiography alone in 28 patients and found a
sensitivity of 82 6 6% and a specificity of 88 6 2% to detect
significant stenoses. Achenbach et al. (41) studied 125
patients with EBCT angiography and reported a sensitivity
of 92% and a specificity of 94% to diagnose high grade
stenoses and occlusions; however, 124 (24.8%) of 500
coronary arteries had to be excluded from analysis because of
poor image quality.
Calcium screening with EBCT should not be interpreted
only in the context of severe coronary stenoses. Exclusion of
stenosis does not guarantee a good prognosis, because small,
unstable plaques may rupture and insignificant disease may
progress to severe disease. Follow-up data, however, are not
yet available for our patients. Our study only included
symptomatic patients. “Symptoms” are a “soft” diagnostic
criterion. Much of our data on prediction of stenosis severity
by calcium screening might well be used to suggest the
severity of stenoses in patients without symptoms (i.e., due
to diabetes mellitus). However, calcium screening in asymp-
tomatic individuals is mostly targeted at the early nonob-
structive stages of atherosclerotic disease. A correlation
could be found between the calcium score in asymptomatic
patients and future cardiac events (42–44). The calcium
score percentiles adjusted for age and gender are signifi-
cantly higher in symptomatic versus asymptomatic patients
with risk factors (45). Prospective studies with a sufficiently
large number of patients are needed to determine the
diagnostic accuracy, cost-effectiveness and potential benefit
of identifying specific patients for primary prevention who
may profit from secondary prevention goals and guidelines
(46–48).
Clinical implications. In patients with typical angina (pro-
voked by physical or emotional stress) and/or a definite
diagnosis of myocardial ischemia on conventional stress
tests, there is no indication for EBCT calcium screening
because of the extremely high pretest likelihood of signifi-
cant stenosis. Coronary angiography is required for the
definite diagnosis and treatment in these patients. On the
basis of our results, we see an indication for calcium
screening in patients with atypical chest pain, especially if
noninvasive tests are not feasible or inconclusive. Calcium
screening with EBCT has the potential as a filter in
symptomatic patients to reduce the number of invasive
procedures which do not lead to intervention.
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